Jason Mast and Matthew Herper

BioTech

As researchers push for a type 1 diabetes cure, Sana Biotechnology provides a nudge forward

Last week, Sana Biotechnology, a once-mysterious and still-buzzy biotech startup, released clinical trial results showing that it had managed to implant insulin-producing cells in the

Jason Mast and Matthew Herper January 16, 2025

BioTech

Top FDA official Peter Marks overruled staff, review team to approve Sarepta gene therapy

For a third time, Sarepta Therapeutics has convinced a top Food and Drug Administration official to overrule the prevailing view of their staff and approve

Jason Mast and Matthew Herper June 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Jason Mast and Matthew Herper

As researchers push for a type 1 diabetes cure, Sana Biotechnology provides a nudge forward

Top FDA official Peter Marks overruled staff, review team to approve Sarepta gene therapy

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe